Loading...
Keywords
Last Name
Institution

Matthew McLaughlin

Concepts (102)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cerebral Palsy
4
2020
11
3.250
Why?
Baclofen
4
2020
8
2.610
Why?
Pharmacogenetics
3
2019
109
1.580
Why?
Dose-Response Relationship, Drug
3
2020
105
1.190
Why?
Muscle Relaxants, Central
2
2020
6
1.090
Why?
Pandemics
2
2020
33
1.050
Why?
Neuromuscular Agents
1
2020
1
0.890
Why?
Rehabilitation
1
2020
1
0.890
Why?
Botulinum Toxins, Type A
1
2020
1
0.890
Why?
Research Support as Topic
1
2020
6
0.880
Why?
Drug Discovery
1
2020
5
0.880
Why?
Pediatrics
2
2020
218
0.830
Why?
Drug Delivery Systems
1
2019
5
0.830
Why?
Practice Patterns, Physicians'
1
2020
89
0.820
Why?
Precision Medicine
1
2019
39
0.790
Why?
Humans
13
2020
5654
0.760
Why?
Child
6
2020
2466
0.720
Why?
Cervical Vertebrae
2
2015
5
0.660
Why?
Arteriovenous Malformations
1
2015
1
0.630
Why?
Thoracic Vertebrae
1
2015
4
0.630
Why?
Spinal Cord
1
2015
6
0.630
Why?
Physical Therapy Modalities
1
2014
4
0.600
Why?
Probability
1
2014
21
0.590
Why?
Models, Statistical
1
2014
30
0.590
Why?
Physical Fitness
1
2010
9
0.440
Why?
Female
7
2020
3292
0.410
Why?
Administration, Oral
2
2020
83
0.410
Why?
Exercise
1
2010
96
0.400
Why?
United States
2
2020
657
0.350
Why?
Retrospective Studies
3
2020
953
0.350
Why?
Genetic Variation
2
2019
146
0.350
Why?
Child, Preschool
3
2020
1443
0.290
Why?
Male
5
2020
3212
0.270
Why?
Adolescent
3
2020
1852
0.270
Why?
Infant
2
2020
1315
0.270
Why?
Patient Selection
2
2020
62
0.240
Why?
Young Adult
2
2020
526
0.240
Why?
Disability Evaluation
1
2020
7
0.230
Why?
Atmospheric Pressure
1
2020
1
0.220
Why?
Personal Protective Equipment
1
2020
1
0.220
Why?
Adenosine Monophosphate
1
2020
1
0.220
Why?
Hydroxychloroquine
1
2020
1
0.220
Why?
Infectious Disease Transmission, Patient-to-Professional
1
2020
1
0.220
Why?
Alanine
1
2020
2
0.220
Why?
Public-Private Sector Partnerships
1
2020
2
0.220
Why?
Metabolome
1
2020
4
0.220
Why?
Vulnerable Populations
1
2020
7
0.220
Why?
Off-Label Use
1
2020
5
0.220
Why?
Antimalarials
1
2020
4
0.220
Why?
Injections, Intramuscular
1
2020
6
0.220
Why?
Tandem Mass Spectrometry
1
2020
24
0.220
Why?
Age Factors
2
2019
227
0.220
Why?
Drug Administration Schedule
1
2020
50
0.220
Why?
Body Weight
1
2020
62
0.220
Why?
Case-Control Studies
1
2020
104
0.220
Why?
Antiviral Agents
1
2020
29
0.210
Why?
Cross-Sectional Studies
1
2020
239
0.210
Why?
Molecular Targeted Therapy
1
2019
10
0.210
Why?
Research Design
1
2019
69
0.200
Why?
Sulfonylurea Receptors
1
2017
3
0.190
Why?
Pharmacological Phenomena
1
2017
1
0.190
Why?
Pharmacokinetics
1
2017
19
0.180
Why?
Prognosis
1
2017
182
0.180
Why?
Polymorphism, Single Nucleotide
1
2017
201
0.170
Why?
Quadriplegia
1
2015
2
0.160
Why?
Magnetic Resonance Imaging
1
2015
72
0.150
Why?
Postmenopause
1
2010
2
0.110
Why?
Delirium
1
2009
1
0.110
Why?
Spinal Cord Diseases
1
2009
2
0.110
Why?
Spine
1
2009
2
0.110
Why?
Motor Activity
1
2010
36
0.110
Why?
Patient Education as Topic
1
2010
69
0.100
Why?
Postoperative Complications
1
2009
150
0.100
Why?
Stereoisomerism
1
2020
7
0.060
Why?
Calibration
1
2020
6
0.060
Why?
Chromatography, Liquid
1
2020
11
0.060
Why?
Drug Monitoring
1
2020
21
0.050
Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
24
0.040
Why?
Coronary Disease
1
1993
6
0.040
Why?
Heart Transplantation
1
1993
15
0.040
Why?
Graft Rejection
1
1993
28
0.040
Why?
Middle Aged
2
2009
561
0.030
Why?
Decompression, Surgical
1
2009
4
0.030
Why?
Methylprednisolone
1
2009
5
0.030
Why?
Recovery of Function
1
2009
13
0.030
Why?
Postoperative Period
1
2009
16
0.030
Why?
Chi-Square Distribution
1
2009
37
0.030
Why?
Hearing Loss
1
2009
7
0.030
Why?
Medical Records
1
2009
16
0.030
Why?
Orthopedic Procedures
1
2009
17
0.030
Why?
Aged, 80 and over
1
2009
114
0.030
Why?
Incidence
1
2009
126
0.030
Why?
Aged
1
2009
292
0.030
Why?
Risk Factors
1
2009
376
0.020
Why?
New York City
1
1993
2
0.010
Why?
Hospitals, University
1
1993
8
0.010
Why?
Survival Rate
1
1993
82
0.010
Why?
Reoperation
1
1993
55
0.010
Why?
Cohort Studies
1
1993
231
0.010
Why?
Time Factors
1
1993
289
0.010
Why?
Treatment Outcome
1
1993
586
0.010
Why?
Adult
1
1993
1065
0.010
Why?
McLaughlin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_